before and after semaglutide NYC ARE WEGOVY® (SEMAGLUTIDE) INJECTIONS PAINFUL?

GLP1s+ Summary In the last 30 years, weve gone from no GLP1s+ or truly scalable weight loss treatments to having treatments that: Efficacy: help patients lose 22% (and still rising) of their weight on average, up from 3-5% Disease Expansion: are approved for diabetes, obesity, cardiovascular disease and soon likely kidney disease and sleep apnea, with more conditions under study Frequency: are taken 1x/week, down from 2x/day (52 times per year versus 730) Form Factor: can be taken orally with more effective options on the horizon Improving the form factor, reducing the burden placed on the patient, all while maintaining and increasing efficacy across weight loss and other cardiometabolic measures, these are incredible feats of science that will benefit humanity in ways we cannot yet comprehend, especially once prices decline

Experimenting with timing can help you find what works best for your schedule and symptom pattern

Indirect effects of GLP-1 include decreasing hepatic gluconeogenesis and increasing neuroprotection in the liver and brain

F., Drynan L., Fan J., Curry A., Fraser G., et al

As we explained in this post, food noise intensifies at night due to stress, circadian imbalance, and hormonal changes, among other factors

Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity